31
Participants
Start Date
June 7, 2000
Primary Completion Date
February 14, 2017
Study Completion Date
July 2, 2024
cisplatin
docetaxel
fluorouracil
gemcitabine hydrochloride
leucovorin calcium
gene expression analysis
protein expression analysis
laboratory biomarker analysis
adjuvant therapy
biopsy
conventional surgery
neoadjuvant therapy
quality-of-life assessment
radiation therapy
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER